Increased production of superoxide anion by macrophages exposed in vitro to muramyl dipeptide or lipopolysaccharide
about
Experimental studies on the effects of organic dust-derived agents on respiratory system: comparison between endotoxins and glucansA low dose of recombinant interleukin 1 protects granulocytopenic mice from lethal gram-negative infectionEnhancement of dengue virus type 2 replication in mouse macrophage cultures by bacterial cell walls, peptidoglycans, and a polymer of peptidoglycan subunitsStimulation of macrophage protease secretion via liposomal delivery of muramyl dipeptide derivatives to intracellular sitesChronic hypersensitivity pneumonitis produced in the rabbit by the adjuvant effect of inhaled muramyl dipeptide (MDP)Phospholipase D is required in the signaling pathway leading to p38 MAPK activation in neutrophil-like HL-60 cells, stimulated by N-formyl-methionyl-leucyl-phenylalanine.Lipophilic derivative of muramyl dipeptide is more active than muramyl dipeptide in priming macrophages to release superoxide anion.Role of lipopolysaccharide in regulating colony-stimulating factor-dependent macrophage proliferation in vitro.Primed stimulation of isolated perfused rabbit lung by endotoxin and platelet activating factor induces enhanced production of thromboxane and lung injury.Biosynthesis and role of the endothelium-derived vasodilator, nitric oxide, in the gastric mucosa.Shedding of the Mer tyrosine kinase receptor is mediated by ADAM17 protein through a pathway involving reactive oxygen species, protein kinase Cδ, and p38 mitogen-activated protein kinase (MAPK).Eradication of spontaneous metastases and activation of alveolar macrophages by intravenous injection of liposomes containing muramyl dipeptide.Endotoxin-induced desensitization of mouse macrophages is mediated in part by nitric oxide production.Low-dose lipopolysaccharide (LPS) pretreatment of mouse macrophages modulates LPS-dependent interleukin-6 production in vitro.Pentoxifylline and CD14 antibody additively inhibit priming of polymorphonuclear leukocytes for enhanced release of superoxide by lipopolysaccharide: possible mechanism of these actionsOnset of apoprotein E secretion during differentiation of mouse bone marrow-derived mononuclear phagocytes.Transmembrane signaling: an ion-flux-independent model for signal transduction by complexed Fc receptorsBacterial lipopolysaccharide suppresses the production of catalytically active lysosomal acid hydrolases in human macrophages.Protective effect of a muramyl dipeptide analog encapsulated in or mixed with liposomes against Candida albicans infectionEnhanced superoxide anion release from phagocytes by muramyl dipeptide or lipopolysaccharide.Activation of macrophages for enhanced release of superoxide anion and greater killing of Candida albicans by injection of muramyl dipeptide.Enhancement of antigen-specific suppression by muramyl dipeptide.Priming of macrophages for enhanced oxidative metabolism by exposure to proteolytic enzymes.Muramyl peptides. Variation of somnogenic activity with structurePriming of neutrophils for enhanced release of oxygen metabolites by bacterial lipopolysaccharide. Evidence for increased activity of the superoxide-producing enzyme.Serum factor requirement for reactive oxygen intermediate release by rabbit alveolar macrophagesMurine Kupffer cells. Mononuclear phagocytes deficient in the generation of reactive oxygen intermediates.Bacterial lipopolysaccharides prime macrophages for enhanced release of arachidonic acid metabolites.Activation of mouse peritoneal macrophages by monoclonal antibodies to Mac-1 (complement receptor type 3)A monoclonal antibody to sialophorin (CD43) induces homotypic adhesion and activation of human monocytes.Collaborative induction of inflammatory responses by dectin-1 and Toll-like receptor 2.Correlation between in vivo anti-Pseudomonas and anti-Candida activities and clearance of carbon by the reticuloendothelial system for various muramyl dipeptide analogs, using normal and immunosuppressed mice.Rap1 induces cytokine production in pro-inflammatory macrophages through NFκB signaling and is highly expressed in human atherosclerotic lesionsCollaboration between the innate immune receptors dectin-1, TLRs, and Nods.In vivo activation of macrophage oxidative burst activity by cytokines and amphotericin B.Altered in vivo activity of liposome-incorporated lipopolysaccharide and lipid A.Capacity of passively administered antibody to prevent establishment of Brucella abortus infection in mice.Oxidative metabolism in cord blood monocytes and monocyte-derived macrophagesActivation of mouse peritoneal adherent cells with N-acyl muramyl dipeptide derivatives.Oxidative metabolic response and microbicidal activity of human milk macrophages: effect of lipopolysaccharide and muramyl dipeptide
P2860
Q23914485-DADEAD8D-593D-42D9-8A6A-F9F92998B89EQ24654068-6BF521B8-C403-40E9-A45E-17FF1D678C76Q27487956-29EF732F-8BBA-4FEA-91A9-F15DDB6E43CCQ28366436-7EA4FEF2-6B32-4B38-9044-3AD4982EB94FQ28396284-FDB4311A-9792-473F-AE06-17F2186A11A0Q33182166-7C8EE0EE-DE59-4EDF-961F-BCB0BF53F183Q33906747-C81C687D-C018-4293-9DFF-A646C182FBD4Q33911519-1875258F-0231-46C1-825A-4714EA33ED52Q34247910-674D27F0-BBFC-40B7-9738-F74126BE5596Q35155556-B3FAD2F4-37EB-4A50-ABA8-FCFA70D4912EQ35312825-4A6680BE-C7A1-45BF-86AC-5C50E9949A59Q35328700-7783BD76-FBD5-4CD7-93C9-7A4C603F0E13Q35410495-A779C1DC-8D6B-475A-9DA2-3CCC18063088Q35476825-F9D32682-3DC0-47F6-BC05-D2B9387CE0D2Q35775033-25F7CB8E-880F-41F2-BB0F-83235F77D980Q36208066-99120E57-2B16-4B03-BCDF-52A384E289C6Q36212014-7C873DF9-249C-44D7-9B18-B0BE9073FD3BQ36215000-1E42D140-3121-48A9-AECB-A652E2F58C99Q36341567-F271A7DD-F525-4EF9-BBAB-81290EA41D9AQ36343846-70746728-E9EB-4209-BD74-D8EFA54B9254Q36344254-F6EF1515-E362-4FD1-9D79-EA8693560198Q36344523-A4A21B56-1E00-49C9-9CF1-A05AB4B9BE78Q36344839-39E805A0-59C6-402B-A2D8-2894287FF7F2Q36348443-E5A0D57D-D5C1-4498-A3F6-D7E7E06D2ABCQ36349700-F0C952E3-6151-47D9-B928-CD26AC1A3982Q36349824-E79CB4F7-C7DB-4D2F-AFAE-9B4911C048A0Q36349948-ABAFA5F7-1838-43A8-98A9-48E0EA57DCA6Q36352129-37D8E393-779E-462F-A1D1-D15ED6D547C5Q36352448-81C7544A-D3F0-4A29-AD4F-0878A9081624Q36356606-08354F3E-4ADE-47D8-BAD5-2110A6DF872FQ36370968-D0027A5F-777E-4C74-98C9-0E446A190E57Q36433792-1A1F76E8-3FC6-473D-BE07-D5C2EAAFD472Q36781142-0660C293-9A52-4F21-9D63-0B9A8BA9F250Q36938606-C8E4033B-664D-4F00-80B3-1232F09C06C3Q36980949-9E4CDB43-2173-4A9C-B237-F54110839B6CQ37005165-EAD70EF8-B47F-4D33-A2CB-0D4CC3402953Q37005752-DF8B3B60-9064-45FB-8225-9F3C31ACC78CQ37031944-5CD8BEBA-F854-4754-82C7-2C13C8D518C1Q37036204-CAE478EF-8D55-4EC2-AA78-2A3E2351BBE2Q37050388-93EB81AF-40AF-48A1-BA16-3E9F915DCED9
P2860
Increased production of superoxide anion by macrophages exposed in vitro to muramyl dipeptide or lipopolysaccharide
description
1980 nî lūn-bûn
@nan
1980年の論文
@ja
1980年学术文章
@wuu
1980年学术文章
@zh-cn
1980年学术文章
@zh-hans
1980年学术文章
@zh-my
1980年学术文章
@zh-sg
1980年學術文章
@yue
1980年學術文章
@zh
1980年學術文章
@zh-hant
name
Increased production of supero ...... ipeptide or lipopolysaccharide
@ast
Increased production of supero ...... ipeptide or lipopolysaccharide
@en
type
label
Increased production of supero ...... ipeptide or lipopolysaccharide
@ast
Increased production of supero ...... ipeptide or lipopolysaccharide
@en
prefLabel
Increased production of supero ...... ipeptide or lipopolysaccharide
@ast
Increased production of supero ...... ipeptide or lipopolysaccharide
@en
P2860
P356
P1476
Increased production of supero ...... ipeptide or lipopolysaccharide
@en
P2093
Johnston RB Jr
P2860
P304
P356
10.1084/JEM.151.1.101
P407
P577
1980-01-01T00:00:00Z